Literature DB >> 1912579

Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates.

R G Andrews1, G H Knitter, S H Bartelmez, K E Langley, D Farrar, R W Hendren, F R Appelbaum, I D Bernstein, K M Zsebo.   

Abstract

Recombinant human stem cell factor (SCF) is homologous with recombinant rat SCF (rrSCF) and is a ligand for c-kit. We determined the influence of SCF on hematopoiesis in vitro and in vivo in baboons. In vitro, SCF alone stimulated little growth of hematopoietic colony-forming cells from baboon marrow, but did increase the number of colonies formed in response to erythropoietin (Epo), interleukin-3 (IL-3), and granulocyte-macrophage colony-stimulating factor (GM-CSF). In vivo, SCF caused an increase in the peripheral blood of the number of erythrocytes, neutrophils, lymphocytes, monocytes, eosinophils, and basophils. In marrow, it caused an increase in marrow cellularity and in the absolute number of colony-forming unit-granulocyte-monocyte (CFU-GM) and burst-forming unit-erythroid (BFU-E) in marrow following infusion of SCF. The in vivo stimulation of multiple lymphohematopoietic lineages corroborates previous in vitro studies and suggests a potentially important clinical role for SCF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912579

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin.

Authors:  T Papayannopoulou; B Nakamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

2.  Stem cell factor affects tumour progression markers in metastatic melanoma cells.

Authors:  Francesca Prignano; Gianni Gerlini; Benedetta Salvatori; Claudio Orlando; Sandra Mazzoli; Nicola Pimpinelli; Silvia Moretti
Journal:  Clin Exp Metastasis       Date:  2006-09-22       Impact factor: 5.150

3.  CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes.

Authors:  Antonia Wimmer; Sophia K Khaldoyanidi; Martin Judex; Naira Serobyan; Richard G Discipio; Ingrid U Schraufstatter
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

Review 4.  Use and toxicity of the colony-stimulating factors.

Authors:  J R Schriber; R S Negrin
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

5.  Paradoxical drop in circulating neutrophil count following granulocyte-colony stimulating factor and stem cell factor administration in rhesus macaques.

Authors:  Brent C Gordon; Amy M Revenis; Aylin C Bonifacino; William E Sander; Mark E Metzger; Allen E Krouse; Tatiana N Usherson; Robert E Donahue
Journal:  Exp Hematol       Date:  2007-06       Impact factor: 3.084

6.  Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy.

Authors:  K Kaushansky; V C Broudy; A Grossmann; J Humes; N Lin; H P Ren; M C Bailey; T Papayannopoulou; J W Forstrom; K H Sprugel
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Spontaneous dissociation-association of monomers of the human-stem-cell-factor dimer.

Authors:  H S Lu; W C Chang; E A Mendiaz; M B Mann; K E Langley; Y R Hsu
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

8.  Reversible expansion of primate mast cell populations in vivo by stem cell factor.

Authors:  S J Galli; A Iemura; D S Garlick; C Gamba-Vitalo; K M Zsebo; R G Andrews
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

9.  Zebrafish Kit ligands cooperate with erythropoietin to promote erythroid cell expansion.

Authors:  Jana Oltova; Ondrej Svoboda; Olga Machonova; Petra Svatonova; David Traver; Michal Kolar; Petr Bartunek
Journal:  Blood Adv       Date:  2020-12-08

10.  Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells.

Authors:  E DeLuca; W P Sheridan; D Watson; J Szer; C G Begley
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.